Gastrointestinal Tolerance
Gastroenterology
1
Pipeline Programs
1
Companies
10
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AbbottABBOTT PARK, IL
10 programs1
Experimental milk protein infant formula Process APhase 31 trial
Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant FormulaN/A1 trial
Experimental 1 Infant FormulaN/A1 trial
Experimental Infant Formula 1N/A1 trial
Experimental Nutritional PuddingN/A1 trial
+5 more programsActive Trials
+7 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AbbottExperimental milk protein infant formula Process A
AbbottHydrolyzed protein infant formula with oligosaccharides
AbbottExperimental Nutritional Pudding
AbbottHydrolysate Infant Formula 1
AbbottTolerUp Enteral Feeding Protocol
AbbottEvaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula
AbbottPhase 1- Arm 1 Infant Formula
AbbottExperimental 1 Infant Formula
AbbottInfant Formula 1
AbbottExperimental Infant Formula 1
Clinical Trials (10)
Total enrollment: 1,317 patients across 10 trials
Tolerance of Healthy Term Infants Fed Infant Formulas #3
Start: Sep 2009Est. completion: Jan 2010270 patients
Phase 3Completed
Infants Fed a Hydrolyzed Infant Formula
Start: May 2022Est. completion: Nov 202333 patients
N/ACompleted
Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk for Malnutrition
Start: Jan 2021Est. completion: Dec 202125 patients
N/ACompleted
Tolerance of Infants Fed a Hydrolysate Formula
Start: Aug 2018Est. completion: Nov 201851 patients
N/ACompleted
TolerUp Enteral Feeding Protocol
Start: Feb 2018Est. completion: Jul 2020133 patients
N/ACompleted
Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula
Start: Jan 2018Est. completion: Mar 2020320 patients
N/ACompleted
Tolerance of Healthy Infants Fed Infant Formulas
Start: Apr 2015Est. completion: Sep 2015126 patients
N/ACompleted
Gastrointestinal Tolerance of Infant Formula
Start: Jan 2015Est. completion: Jun 2015131 patients
N/ACompleted
Alternate Formula Feedings in Formula Intolerant Infants
Start: Aug 1996Est. completion: Jun 1997113 patients
N/ACompleted
Soy Formula Feedings in Healthy, Term Infants
Start: Dec 1992Est. completion: Jun 1994115 patients
N/ACompleted
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
7h ago
Key Account Director, Diagnostics and Research
Tempus
Remote
20h ago
$150K - $200K/yr
Experienced Clin Programmer
Johnson & Johnson
High Wycombe, Buckinghamshire, United Kingdom
20h ago
[Innovative Medicine] Director, Government Affairs and Policy Dept., Integrated Market Access Div.
Johnson & Johnson
Chiyoda, Tokyo, Japan
20h ago
Analyst Accounting
Johnson & Johnson
Suzhou, Jiangsu, China
20h ago
Lead Product Security Engineer
Johnson & Johnson
Danvers, Massachusetts, United States of America
20h ago
$94K - $152K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space